Related references
Note: Only part of the references are listed.Multiple sclerosis patients with anti-lipid oligoclonal IgM show early favourable response to immunomodulatory treatment
N. Garcia-Barragan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Effect of relapses over early progression of disability in multiple sclerosis patients treated with beta-interferon
I. Bosca et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis
M. Thangarajh et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Predicting beta-interferon failure in relapsing-remitting multiple sclerosis
K. O'Rourke et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
L. Kappos et al.
NEUROLOGY (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Identifying and treating patients with suboptimal responses
BA Cohen et al.
NEUROLOGY (2004)
An ultrasensitive method for the detection of oligoclonal IgG bands
MC Sadaba et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis
LM Villar et al.
ANNALS OF NEUROLOGY (2003)
Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS
LM Villar et al.
NEUROLOGY (2002)
Intrathecal IgM synthesis in neurologic diseases:: Relationship with disability in MS
LM Villar et al.
NEUROLOGY (2002)
A sensitive and reproducible method for the detection of oligoclonal IgM bands
LM Villar et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Effect of early interferon treatment on conversion to definite multiple sclerosis:: a randomised study
G Comi et al.
LANCET (2001)
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis.
LD Jacobs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
